APA (7th ed.) Citation

H, Z., R, G., H, F., J, J., M, L., Z, S., . . . L, C. (2026). Deep gray matter atrophy mediates the associations between glymphatic dysfunction and clinical disability in relapsing-remitting multiple sclerosis: A neuroimaging subgroup study. Frontiers in immunology, 17, 1758859. https://doi.org/10.3389/fimmu.2026.1758859

Chicago Style (17th ed.) Citation

H, Zhang, et al. "Deep Gray Matter Atrophy Mediates the Associations Between Glymphatic Dysfunction and Clinical Disability in Relapsing-remitting Multiple Sclerosis: A Neuroimaging Subgroup Study." Frontiers in Immunology 17 (2026): 1758859. https://doi.org/10.3389/fimmu.2026.1758859.

MLA (9th ed.) Citation

H, Zhang, et al. "Deep Gray Matter Atrophy Mediates the Associations Between Glymphatic Dysfunction and Clinical Disability in Relapsing-remitting Multiple Sclerosis: A Neuroimaging Subgroup Study." Frontiers in Immunology, vol. 17, 2026, p. 1758859, https://doi.org/10.3389/fimmu.2026.1758859.